Historische Organisatie
Gavi
A news release described a March vaccination campaign using Men5CV against five meningococcal groups.
The article explains why vaccination was undertaken in affected Nigerian states.
Men5CV can protect against several causes of meningococcal meningitis, depending on the group.
The entry is dated to WHO’s 12 April report; the initial rollout took place in March.
